Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination.

Published in:

2016

By:

• Lambert-Niclot, S.;
• Allavena, C.;
• Grude, M.;
• Flandre, P.;
• Sayon, S.;
• Andre, E.;
• Wirden, M.;
• Rodallec, A.;
• Jovelin, T.;
• Katlama, C.;
• Calvez, V.;
• Raffi, F.;
• Marcelin, A.-G.

Publication type:

journal article